Morgan Stanley
ELX

Morgan Stanley’s EMULEX CORP ELX Stock Holding History

Morgan Stanley’s Portfolio ELX Stock Details ELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,108,394
Closed -$8.83M – 6969
2015
Q1 		$8.83M Buy
1,108,394
+386,335
+54% +$2.71M ﹤0.01% 2184
2014
Q4 		$4.09M Buy
722,059
+390,509
+118% +$2.1M ﹤0.01% 2912
2014
Q3 		$1.64M Sell
331,550
-64,770
-16% -$351K ﹤0.01% 3599
2014
Q2 		$2.26M Sell
396,320
-89,287
-18% -$531K ﹤0.01% 3389
2014
Q1 		$3.59M Sell
485,607
-1,804,767
-79% -$13.3M ﹤0.01% 2898
2013
Q4 		$16.4M Buy
2,290,374
+814,408
+55% +$6.05M 0.01% 1518
2013
Q3 		$11.5M Sell
1,475,966
-204,984
-12% -$1.59M 0.01% 1668
2013
Q2 		$11M Buy
+1,680,950
New +$10.6M 0.01% 1628

Morgan Stanley's ELX Position: Q2 2015 in Review

Morgan Stanley sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 1,108,394 shares — an estimated $8.83M sold.

Morgan Stanley first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $16.4M in Q4 2013. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Morgan Stanley reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Morgan Stanley sold 1,108,394 EMULEX CORP shares in Q2 2015, an estimated $8.83M.
  • Morgan Stanley first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Morgan Stanley's EMULEX CORP position peaked at $16.4M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.